📈 Profit Update on Centene Corp. (CNC): 65% Options Gain on the $40 Strike Call

Date Published: 

When we issued our earlier analysis on Centene Corp. (CNC), the stock was spiraling lower. Shares had collapsed into the high $20s, and we highlighted that the panic-driven selloff created a rare asymmetric opportunity for options traders. Specifically, we recommended the Jan 2027 $40 Call as a high-upside LEAPS entry.

Today, CNC has rebounded into the mid-$30s, and the $40 call has surged in value — delivering substantial returns. Let’s revisit what has changed, compare old vs. new data, and quantify the gains.


🔙 CNC Back Then

At the time of our first callout:

  • Stock Price: ~$28–29
  • RSI: Deep oversold at ~25, a level historically tied to exhaustion selling.
  • MACD: Strongly negative, but showing early signs of flattening.
  • Options Chain: The $40 strike call was trading at just $3.90.

This was a contrarian setup — extreme fear combined with long-dated LEAPS at attractive pricing.




📊 CNC Now

Fast-forward to today:

  • Stock Price: ~$34.86
  • RSI: Back to ~67 on the daily chart, signaling bullish momentum from extreme lows.
  • MACD: Both daily and weekly MACD have flipped positive, confirming momentum shift.
  • Options Chain: The $40 strike call now trades at $6.45.




💰 Profit Breakdown

  • Old Price (Then): $3.90
  • New Price (Now): $6.45
  • Profit per Contract: $2.55
  • Total Dollar Profit (100 shares): $255
  • Percentage Gain: ~65%

That means a $390 investment in one contract has grown to $645, in just a few months.


🔍 Technical Comparison

  • Then: Oversold RSI, collapsing price, capitulation selling.
  • Now: RSI rebounded strongly, MACD bullish, volume accumulation visible. CNC has formed a higher base in the $30–35 range, strengthening the case for continued recovery.


🚦 Takeaway

Our CNC options thesis has played out as expected. If you had followed the recommendation to buy the Jan 2027 $40 Call, you’d now be up 65% on your position.

This highlights why LEAPS strategies in oversold, fundamentally stable companies can deliver outsized returns with relatively modest capital outlay.

The next key technical test will be the $35–38 resistance zone. If CNC breaks above, the $40 calls could move even deeper into the money, amplifying gains further.


✅ Disclaimer: This update is for educational and informational purposes only. It does not constitute financial advice. Options trading involves substantial risk and may not be suitable for all investors. Always conduct your own due diligence and consult a licensed financial advisor before making any investment decisions.

Latest News for CNC

CENTENE CORPORATION TO HOST 2026 THIRD QUARTER FINANCIAL RESULTS EARNINGS CALL

ST. LOUIS, Oct. 19, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 third quarter financial results at approximately 6:00 a.m. ET on Tuesday, October 27, 2026, and host a conference call at 8:30 a.m.

PRNewsWire • Oct 19, 2026
Centene Corporation Demonstrates Commitment to CHOICE Arrangements through Benefit Programs in Indiana, Ohio and Oklahoma

Expansion into Ohio and Oklahoma for plan year 2027 builds on early success offering employees  CHOICE Arrangements in Indiana in 2026 ST. LOUIS, Oct. 16, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced the expansion of its CHOICE Arrangements benefit program (formerly ICHRA) to employees in Ohio and Oklahoma for plan…

PRNewsWire • Oct 16, 2026
PA Health & Wellness Earns National Recognition Among Top Medicaid Health Plans for Second Consecutive Year

MECHANICSBURG, Pa., Oct. 13, 2026 /PRNewswire/ -- PA Health & Wellness, a leading managed care organization in Pennsylvania and a company of Centene Corporation (NYSE: CNC), today announced that it has been recognized among the top 17 Medicaid health plans in the United States by the National Committee for Quality Assurance (NCQA) for the second consecutive year.

PRNewsWire • Oct 13, 2026

Analyst Price Targets — CNC

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 18, 2026 11:24 am—UBS$79.00$64.43StreetInsider Bernstein SocGen Group Reiterates Outperform Rating on Centene (CNC), discusses CFO change
August 11, 2026 11:10 amJohn StaszakArgus Research$80.00$66.56StreetInsider Argus Upgrades Centene (CNC) to Buy
August 3, 2026 1:18 pm—Bernstein$79.00$62.37TheFly Centene price target raised to $79 from $68 at Bernstein
August 3, 2026 9:31 am—Stifel Nicolaus$79.00$62.22StreetInsider Centene (CNC) PT Raised to $79 at Bernstein SocGen Group
July 29, 2026 3:53 pmErin WrightMorgan Stanley$66.00$62.27TheFly Centene price target raised to $66 from $57 at Morgan Stanley
July 29, 2026 10:43 am—Robert W. Baird$66.00$64.02TheFly Centene price target raised to $66 from $46 at Baird
July 29, 2026 9:09 amAndrew MokBarclays$80.00$64.02TheFly Centene price target raised to $80 from $75 at Barclays
July 14, 2026 11:50 amDavid MacDonaldTruist Financial$78.00$68.29TheFly Centene price target raised to $78 from $71 at Truist
July 13, 2026 11:06 am—Wells Fargo$69.00$67.35TheFly Centene price target raised to $69 from $56 at Wells Fargo
July 7, 2026 11:08 amSarah JamesRaymond James$75.00$66.05TheFly Centene price target raised to $75 from $60 at Cantor Fitzgerald

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CNC.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top